Shopping Cart 0
Cart Subtotal
USD 0

Biotest AG (BIO) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375

Details

Biotest AG (BIO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biotest AG (Biotest) provides pharmaceutical and biotherapeutic drugs. It develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products comprise clotting factors, immunoglobulins, albumin and monoclonal antibodies in clinical development. The company specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest distributes its products through local marketing partners and distributors in Europe, North America, South America, Asia, the Middle East and Africa. It has subsidiaries and sales companies in Austria, Switzerland, France, Great Britain, Italy, Hungary, Spain and in Brazil. Biotest is headquartered in Dreieich, Hessen, Germany.

Biotest AG Key Recent Developments

Dec 11,2019: Biotest opens fourth plasma collection centre in Czech Republic

Dec 04,2019: Biotest increases Guidance

Nov 14,2019: Biotest : Biotest increases sales by 1.8% to EUR 294.9 million

Aug 14,2019: Biotest increases adjusted EBIT by 12% to EUR 29.9 million

Jul 05,2019: Biotest reaches revenues of EUR 77.5 million in the first quarter 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Biotest AG-Key Facts

Biotest AG-Key Employees

Biotest AG-Key Employee Biographies

Biotest AG-Key Operational Employees

Biotest AG-Major Products and Services

Biotest AG-History

Biotest AG-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Biotest AG-Business Description

Business Segment: Other Segments

Overview

Performance

Business Segment: Plasma & Services

Overview

Performance

Business Segment: Therapy

Overview

Performance

Geographical Segment: Central Europe

Performance

Geographical Segment: East and South Europe

Performance

Geographical Segment: Intercontinental

Performance

Geographical Segment: Middle East, Africa and France

Performance

R&D Overview

Biotest AG-Corporate Strategy

Biotest AG-SWOT Analysis

SWOT Analysis-Overview

Biotest AG-Strengths

Biotest AG-Weaknesses

Biotest AG-Opportunities

Biotest AG-Threats

Biotest AG-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Biotest AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020

Biotest AG, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020

Biotest AG, Recent Deals Summary

Section 5-Company's Recent Developments

Dec 11, 2019: Biotest opens fourth plasma collection centre in Czech Republic

Dec 04, 2019: Biotest increases Guidance

Nov 14, 2019: Biotest : Biotest increases sales by 1.8% to EUR 294.9 million

Aug 14, 2019: Biotest increases adjusted EBIT by 12% to EUR 29.9 million

Jul 05, 2019: Biotest reaches revenues of EUR 77.5 million in the first quarter 2019

May 07, 2019: Biotest reaches revenues of EUR 77.5 million in the first quarter 2019

Apr 09, 2019: Biotest opens ninth plasma collection centre in Hungary

Mar 28, 2019: Biotest increases operating result by EUR 20 million in 2018

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Biotest AG, Performance Chart (2014-2018)

Biotest AG, Ratio Charts

Biotest AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020

Biotest AG, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020


List Of Table

List of Tables

Biotest AG, Key Facts

Biotest AG, Key Employees

Biotest AG, Key Employee Biographies

Biotest AG, Key Operational Employees

Biotest AG, Major Products and Services

Biotest AG, History

Biotest AG, Other Locations

Biotest AG, Subsidiaries

Biotest AG, Key Competitors

Biotest AG, Ratios based on current share price

Biotest AG, Annual Ratios

Biotest AG, Annual Ratios (Cont...1)

Biotest AG, Annual Ratios (Cont...2)

Biotest AG, Interim Ratios

Biotest AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020

Biotest AG, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020

Biotest AG, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Biotest AG, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Viramed Biotech AG

Takeda Pharmaceutical Co Ltd

Medivir AB

Halozyme Therapeutics Inc

Grifols SA

Celltrion Inc

Company Profile

Company Profile Title

Biotest AG (BIO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biotest AG (Biotest) provides pharmaceutical and biotherapeutic drugs. It develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products comprise clotting factors, immunoglobulins, albumin and monoclonal antibodies in clinical development. The company specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest distributes its products through local marketing partners and distributors in Europe, North America, South America, Asia, the Middle East and Africa. It has subsidiaries and sales companies in Austria, Switzerland, France, Great Britain, Italy, Hungary, Spain and in Brazil. Biotest is headquartered in Dreieich, Hessen, Germany.

Biotest AG Key Recent Developments

Dec 11,2019: Biotest opens fourth plasma collection centre in Czech Republic

Dec 04,2019: Biotest increases Guidance

Nov 14,2019: Biotest : Biotest increases sales by 1.8% to EUR 294.9 million

Aug 14,2019: Biotest increases adjusted EBIT by 12% to EUR 29.9 million

Jul 05,2019: Biotest reaches revenues of EUR 77.5 million in the first quarter 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Biotest AG-Key Facts

Biotest AG-Key Employees

Biotest AG-Key Employee Biographies

Biotest AG-Key Operational Employees

Biotest AG-Major Products and Services

Biotest AG-History

Biotest AG-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Biotest AG-Business Description

Business Segment: Other Segments

Overview

Performance

Business Segment: Plasma & Services

Overview

Performance

Business Segment: Therapy

Overview

Performance

Geographical Segment: Central Europe

Performance

Geographical Segment: East and South Europe

Performance

Geographical Segment: Intercontinental

Performance

Geographical Segment: Middle East, Africa and France

Performance

R&D Overview

Biotest AG-Corporate Strategy

Biotest AG-SWOT Analysis

SWOT Analysis-Overview

Biotest AG-Strengths

Biotest AG-Weaknesses

Biotest AG-Opportunities

Biotest AG-Threats

Biotest AG-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Biotest AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020

Biotest AG, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020

Biotest AG, Recent Deals Summary

Section 5-Company's Recent Developments

Dec 11, 2019: Biotest opens fourth plasma collection centre in Czech Republic

Dec 04, 2019: Biotest increases Guidance

Nov 14, 2019: Biotest : Biotest increases sales by 1.8% to EUR 294.9 million

Aug 14, 2019: Biotest increases adjusted EBIT by 12% to EUR 29.9 million

Jul 05, 2019: Biotest reaches revenues of EUR 77.5 million in the first quarter 2019

May 07, 2019: Biotest reaches revenues of EUR 77.5 million in the first quarter 2019

Apr 09, 2019: Biotest opens ninth plasma collection centre in Hungary

Mar 28, 2019: Biotest increases operating result by EUR 20 million in 2018

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Biotest AG, Performance Chart (2014-2018)

Biotest AG, Ratio Charts

Biotest AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020

Biotest AG, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020


List Of Table

List of Tables

Biotest AG, Key Facts

Biotest AG, Key Employees

Biotest AG, Key Employee Biographies

Biotest AG, Key Operational Employees

Biotest AG, Major Products and Services

Biotest AG, History

Biotest AG, Other Locations

Biotest AG, Subsidiaries

Biotest AG, Key Competitors

Biotest AG, Ratios based on current share price

Biotest AG, Annual Ratios

Biotest AG, Annual Ratios (Cont...1)

Biotest AG, Annual Ratios (Cont...2)

Biotest AG, Interim Ratios

Biotest AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020

Biotest AG, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020

Biotest AG, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Biotest AG, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Viramed Biotech AG

Takeda Pharmaceutical Co Ltd

Medivir AB

Halozyme Therapeutics Inc

Grifols SA

Celltrion Inc